By simultaneously targeting multiple hormonal pathways, it offers a comprehensive approach to diabetes management
While these considerations remain provisional and require validation, they provide a structured direction for future trial design and help move this concept toward a more individualized, redox-guided strategy
Moss CE, Marsh WJ, Parker HE, Ogunnowo-Bada E, Riches CH, Habib AM, et al
Introduction Autoimmune thyroid diseases (AITD), namely autoimmune thyroiditis (AIT)/Hashimotos thyroiditis (HT), Graves disease (GD), Graves ophthalmopathy (GO), are complex, polygenic lesions with both similarities and differences that largely programmed by genetic factors (1, 2)